As state bans and other restrictions have been ready to go into effect, the demand for mail-order abortion medication has increased. The Supreme Court’s announcement to review the FDA’s changes on their abortion pills has left many Americans considering how to get safe and legal abortions within the barriers being put in place. The FDA, though making abortion pills somewhat accessible, they are still very regulated in comparison to other drugs approved by the FDA. Northeastern Law Professor shares her knowledge on the abortion medication Mifepristone and how these changes may impact the future of abortion care.
“[Mifepristone is] relatively rare in that the FDA is explicit in how it can be administered,”
Wendy Parmet, Professor of Law and WGSS affiliated faculty – and a member of the Reproductive Justice Research Collaborative team of principal investigators.
Read the full story here.
